Hi @ozgoldtrader, The stock price did overshoot in a major way to the downside prior to a major change in sentiment .Definitely more shares on issue now but many of the new shares could be held by investors in this for more than a trade.
I remember as a large investor in Sirtex , at times it looked horrific , when trading around $ 40 to back under $ 10 and then to trade much higher again before being taken over for $1.9 billion. This sector is particularly brutal as investors have seen. Increase awareness , building infrastructure, approvals , distribution , trials , new and existing investors increasing holdings
( some in this at a higher sp ) could mean Sales whilst great are not the main play here and a take over is. Everyone should do there own research but in my opinion risk vs reward looks very good from where it is currently trading.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
OSL
oncosil medical ltd
Add to My Watchlist
1.05%
!
96.0¢

Hi @ozgoldtrader, The stock price did overshoot in a major way...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
96.0¢ |
Change
0.010(1.05%) |
Mkt cap ! $13.65M |
Open | High | Low | Value | Volume |
$1.00 | $1.03 | 96.0¢ | $12.69K | 13.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1185 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.05 | 8827 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1185 | 1.000 |
1 | 15 | 0.985 |
2 | 16677 | 0.950 |
1 | 819 | 0.940 |
1 | 627 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
1.050 | 8827 | 2 |
1.075 | 1879 | 1 |
1.080 | 48 | 1 |
1.090 | 375 | 1 |
1.180 | 2500 | 1 |
Last trade - 10.30am 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online